Vericel Corporation (VCEL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Vericel Corporation, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$41.09
−5.04% today
Market cap
$2.2B
Overall quality
—
Kronos AI 30-day
−0.0%
4 of 8 simulated paths end higher
Vericel Corporation (VCEL) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $2.2B. It trades at $41.09, down 5.04% today. 3 analysts' average target of $60.25 implies +46.6% from today's price. Kronos AI's 30-day forecast is −0.0% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $60.25 |
| Low – high | $52.00 – $72.00 |
| Analysts | 3 |
| Upside to average | +46.6% |
Kronos AI 30-day forecast
| Expected close | $43.25 (−0.0%) |
| Likely range | −4.6% … +5.0% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.